Want to see AU:GLH full AI Analyst Report?
Global Health Limited (GLH) Ratios
Global Health Limited Ratios
AU:GLH's free cash flow for Q4 2026 was $-120.21K. For the 2026 fiscal year, AU:GLH's free cash flow was decreased by $-3.00 and operating cash flow was $-120.21K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.34 | 0.53 | 0.60 | 0.66 | 1.49 |
| Quick Ratio | 0.34 | 0.53 | 0.60 | 0.66 | 1.49 |
| Cash Ratio | 0.13 | 0.26 | 0.40 | 0.48 | 1.32 |
| Solvency Ratio | -0.12 | -0.13 | -0.22 | -1.60 | -0.36 |
| Operating Cash Flow Ratio | -0.03 | -0.13 | -0.22 | -0.74 | -0.25 |
| Short-Term Operating Cash Flow Coverage | -0.19 | -2.56 | -6.32 | -77.03 | -8.38 |
| Net Current Asset Value | $ -4.46M | $ -3.75M | $ -2.92M | $ -1.63M | $ 2.23M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.82 | 0.51 | 0.33 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | -0.37 | -0.39 | -0.35 | -0.03 | 0.02 |
| Debt-to-Capital Ratio | -0.58 | -0.64 | -0.55 | -0.03 | 0.02 |
| Long-Term Debt-to-Capital Ratio | -0.15 | -0.46 | -0.41 | 0.00 | -0.01 |
| Financial Leverage Ratio | -0.45 | -0.76 | -1.06 | -1.93 | 1.81 |
| Debt Service Coverage Ratio | -0.46 | 1.54 | -6.91 | -120.34 | -9.94 |
| Interest Coverage Ratio | -7.55 | -9.41 | -23.09 | -209.61 | -59.28 |
| Debt to Market Cap | 0.46 | 0.37 | 0.15 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.03 | 0.03 | 0.02 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.64 | -0.10 | 0.59 | 0.31 | 3.68 |
| Profitability Margins | |||||
| Gross Profit Margin | -7.89% | 24.21% | -8.49% | -27.91% | -10.16% |
| EBIT Margin | -19.55% | -9.25% | -21.81% | -98.26% | -30.32% |
| EBITDA Margin | -19.41% | -9.15% | -21.74% | -92.02% | -25.92% |
| Operating Profit Margin | -19.55% | -9.15% | -21.68% | -47.70% | -30.23% |
| Pretax Profit Margin | -22.17% | -10.00% | -16.15% | -98.49% | -30.75% |
| Net Profit Margin | -10.55% | -10.00% | -16.15% | -103.03% | -31.35% |
| Continuous Operations Profit Margin | -10.55% | 5.54% | -16.15% | -103.03% | -31.35% |
| Net Income Per EBT | 47.62% | 100.00% | 100.00% | 104.61% | 101.94% |
| EBT Per EBIT | 113.38% | 109.28% | 74.49% | 206.49% | 101.72% |
| Return on Assets (ROA) | -38.24% | -30.51% | -42.64% | -258.20% | -18.57% |
| Return on Equity (ROE) | 17.03% | 23.20% | 45.24% | 497.30% | -33.67% |
| Return on Capital Employed (ROCE) | 36.58% | 31.40% | 86.45% | 237.05% | -31.81% |
| Return on Invested Capital (ROIC) | 23.84% | -19.54% | 94.79% | 244.03% | -31.10% |
| Return on Tangible Assets | -38.24% | -30.51% | -42.64% | -258.20% | -27.19% |
| Earnings Yield | -21.52% | -21.91% | -18.83% | -103.74% | -15.91% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.54 | 8.11 | 9.91 | 11.11 | 12.01 |
| Payables Turnover | 20.55 | 20.25 | 18.28 | 15.99 | 12.43 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 583.75 | 730.10 | 396.77 | 885.59 | 673.26 |
| Asset Turnover | 3.62 | 3.05 | 2.64 | 2.51 | 0.59 |
| Working Capital Turnover Ratio | -2.25 | -3.77 | -4.46 | 20.33 | 4.06 |
| Cash Conversion Cycle | 30.62 | 26.99 | 16.86 | 10.02 | 1.02 |
| Days of Sales Outstanding | 48.38 | 45.02 | 36.83 | 32.85 | 30.39 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 17.76 | 18.02 | 19.97 | 22.83 | 29.37 |
| Operating Cycle | 48.38 | 45.02 | 36.83 | 32.85 | 30.39 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.06 | -0.02 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.08 | -0.04 |
| Dividend Paid and CapEx Coverage Ratio | -18.24 | -353313.50 | -64.81 | -3.87 | -1.32 |
| Capital Expenditure Coverage Ratio | -18.24 | -353313.50 | -64.81 | -3.87 | -1.32 |
| Operating Cash Flow Coverage Ratio | -0.12 | -0.48 | -1.10 | -77.03 | -8.34 |
| Operating Cash Flow to Sales Ratio | -0.03 | -0.08 | -0.14 | -0.44 | -0.18 |
| Free Cash Flow Yield | -5.88% | -17.87% | -16.51% | -56.09% | -16.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.65 | -4.56 | -5.31 | -0.96 | -6.29 |
| Price-to-Sales (P/S) Ratio | 0.49 | 0.46 | 0.86 | 0.99 | 1.97 |
| Price-to-Book (P/B) Ratio | -0.79 | -1.06 | -2.40 | -4.79 | 2.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -17.02 | -5.60 | -6.06 | -1.78 | -6.20 |
| Price-to-Operating Cash Flow Ratio | -17.95 | -5.60 | -6.15 | -2.24 | -10.89 |
| Price-to-Earnings Growth (PEG) Ratio | 0.35 | 0.13 | 0.06 | -0.00 | -0.03 |
| Enterprise Value Multiple | -3.17 | -5.09 | -3.36 | -0.77 | -3.92 |
| Enterprise Value | 4.41M | 4.03M | 5.93M | 5.57M | 6.65M |
| EV to EBITDA | -3.17 | -5.09 | -3.36 | -0.77 | -3.92 |
| EV to Sales | 0.61 | 0.47 | 0.73 | 0.71 | 1.02 |
| EV to Free Cash Flow | -21.32 | -5.71 | -5.15 | -1.28 | -3.20 |
| EV to Operating Cash Flow | -22.49 | -5.71 | -5.23 | -1.61 | -5.62 |
| Tangible Book Value Per Share | -0.08 | -0.06 | -0.05 | -0.03 | 0.05 |
| Shareholders’ Equity Per Share | -0.08 | -0.06 | -0.05 | -0.03 | 0.11 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.52 | 1.55 | 0.00 | -0.05 | -0.02 |
| Revenue Per Share | 0.12 | 0.15 | 0.14 | 0.14 | 0.12 |
| Net Income Per Share | -0.01 | -0.01 | -0.02 | -0.14 | -0.04 |
| Tax Burden | 0.48 | 1.00 | 1.00 | 1.05 | 1.02 |
| Interest Burden | 1.13 | 1.08 | 0.74 | 1.00 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.24 | 0.33 | 0.28 | 0.09 |
| SG&A to Revenue | 0.12 | 0.09 | 0.74 | 0.90 | 0.88 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Income Quality | 0.26 | 0.82 | 0.86 | 0.43 | 0.58 |
Currency in AUD